Amlodipine Besylate
Product Images NDC 69150-114

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 69150-114). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biomes Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amlodipine 10mg 90count

Amlodipine Besylate Tablets, USP 10 mg strength, packaged in a container of 90 tablets. The label specifies the manufacturer as Biomes Pharmaceuticals LLC and includes storage instructions to keep the tablets at 20°C to 25°C (68°F to 77°F) with permitted excursions. The label also notes the requirement to dispense in tight, light-resistant containers and the batch number N.L.M. No.: TN0002326.*

FDA Label Image

Amlodipine 5mg 90count

Amlodipine Besylate Tablets, USP 5 mg label from BIOMES PHARMACEUTICALS LLC. The label indicates prescription-only status (Rx Only) and contains 90 tablets. It includes dosage details, storage instructions at 20° to 25°C (68° to 77°F), and manufacturer information: Vinnmed Life Sciences Private Limited, India, and Biomes Pharmaceuticals LLC, Lansing, MI. The NDC number is 69150-114-90.*

FDA Label Image

Amlodipine Label 2 5mg 90count

Amlodipine Besylate Tablets, USP 2.5 mg label from Biomes Pharmaceuticals LLC. The label states each tablet contains 2.5 mg amlodipine, includes storage instructions to keep between 20° to 25°C, and mentions dispensing information. The package size is 90 tablets. The label also includes the NDC 69150-113-90 and barcode.*

FDA Label Image

Description (C2547a70 38b0 44a5 B9f1 F0a8c776e2c9 01)

Chemical structure diagram of amlodipine besylate, depicting its molecular framework with atoms and bonds clearly illustrated. The molecular formula C20H25ClN2O5S is shown below the structure. This image visually represents the active ingredient amlodipine besylate.*

FDA Label Image

Figure 1 (C2547a70 38b0 44a5 B9f1 F0a8c776e2c9 02)

A line chart comparing the event rate over time (in months) between Amlodipine and placebo groups. The graph includes hazard ratio, confidence intervals, and p-value statistics, showing separate event rate curves for Amlodipine and placebo treatments.*

FDA Label Image

Figure 2 (C2547a70 38b0 44a5 B9f1 F0a8c776e2c9 03)

A forest plot chart displaying hazard ratios with 95% confidence intervals comparing Amlodipine to placebo. It includes subgroups by age, gender, baseline sitting systolic blood pressure, baseline vessel disease, vessel stenosis, and PCI-stent status, showing point estimates and confidence intervals along a horizontal axis ranging from 0 to 2. The overall patient population is 1318.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.